Chart of the day: China shoots up ranks of pharma markets

From FT story on how Japanese pharma Eisai has penetrated China's growing market well before its national competitors.

Reason why is that China is rapidly moving up the ranks from 10th place in 2004 to third, after Japan and the US, by 2014.

Usual bottom-of-the-pyramid reality:

Emerging markets, particularly China, are becoming increasingly important for drugmakers, which have to deal with slowing growth at home.

The big driver in China?  The gov's $125B overhaul of the country's weak health system.